Self -assembled drug -loaded nanoprobes for pyroptosis sensitization and chemical exchange saturation transfer imaging in breast cancer

doi:10.3969/j.issn.1674-8115.2025.03.003

Abstract

Abstract:

Objective ·To prepare self-assembled drug-loaded nanoprobes with activatable chemical exchange saturation transfer (CEST) imaging capability, and evaluate their imaging performance and therapeutic potential for photodynamic-sensitized pyroptosis in breast cancer in vivo and in vitro. Methods ·GC nanoprobes co-loaded with gemcitabine (Gem) and chlorin e6 (Ce6) were constructed by using a self-assembly strategy. The physicochemical properties of the GC nanoprobes were characterized by scanning electron microscopy (SEM) and dynamic light scattering (DLS). The pH-/time-dependent CEST activation and drug release profiles were investigated. The 2 ',7 '-dichlorodihydrofluorescein diacetate (DCFH-DA) probe was used to detect the generation of reactive oxygen species (ROS), and enzyme-linked immunosorbent assay (ELISA) was used to detect the release of inflammatory factors such as interleukin-1β (IL-1β) and IL-18 in mouse breast cancer 4T1 cells after treatment with GC nanoprobes with synergistic laser irradiation. Immunofluorescence was performed to detect immunogenic cell death (ICD) markers, including calreticulin (CRT) and high mobility group box 1 protein (HMGB1). The 4T1 breast cancer mouse models were established to validate tumor-specific CEST activation and evaluate anti-tumor efficacy by measuring tumor volume and detecting inflammatory factors and ICD markers. Results ·SEM and DLS confirmed the uniform spherical morphology of the GC nanoprobes. The CEST imaging results showed that the nanoprobes had excellent pH-concentration and time-dependent activation imaging effects both in the simulated acidic microenvironment and at the cellular level in vitro. The drug release from this drug-loaded nanoprobe was 80% at pH 5.0, which was significantly higher than at pH 7.4 ( P=0.003). DCFH-DA fluorescence staining demonstrated that GC-mediated photodynamic therapy induced a significant generation of ROS. Analysis of pyroptosis-related factors revealed a marked increase in the release levels of IL-1β and IL-18 (both P<0.05), along with elevated fluorescence expression of CRT and HMGB1. The in vivo CEST imaging results showed that the CEST signal at the tumor site was significantly enhanced, peaking at 4 h with tail vein injection of GC. The GC nanoprobes with synergistic laser irradiation group showed markedly elevated inflammatory factors (IL-1β, IL-18), changed ICD biomarkers (HMGB1 and CRT), and significant tumor suppression, compared to the PBS control group (all P<0.05) . Conclusion ·The GC nanoprobes enables specific CEST imaging-guided photodynamic therapy, effectively inducing pyroptosis and precise ablation of breast cancer.

Key words: chemical exchange saturation transfer (CEST) imaging, pyroptosis, nanoprobe, breast cancer

CLC Number:

R445

DENG Jiali, GUO Jiajing, WANG Jingyi, DING Xinyi, ZHU Yi, WANG Zhongling. Self -assembled drug -loaded nanoprobes for pyroptosis sensitization and chemical exchange saturation transfer imaging in breast cancer[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(3): 271-281.

Figures/Tables 9

Fig 1 Characterization of GC nanoprobes as well as generation capacity of 1O2 and drug release capacity at different pH values

Fig 2 Effects of GC nanoprobes combined with laser irradiation on the proliferation and intracellular ROS generation in mouse breast cancer 4T1 cells

Fig 3 In vitro CEST imaging of Gem at different concentrations and GC nanoprobes at different pH values

Fig 4 Cellar uptake of GC nanoprobes in mouse breast cancer 4T1 cells

Fig 5 Responsive CEST imaging of GC nanoprobes in tumor cells and normal cells

Fig 6 Pyroptosis-inducing ability and triggered immune responses of photosensitized GC nanoprobes with PDT sensitization in 4T1 cells

Fig 7 In vivo CEST imaging study of GC nanoprobes

Fig 8 Pyroptosis-mediated in vivo antitumor effects of GC nanoprobes

Fig 9 H-E staining of major organs in mice after GC nanoprobes combined with laser irradiation therapy

TrendMD

References 19

1	HARBECK N, GNANT M. Breast cancer[J]. Lancet, 2017, 389(10074): 1134-1150.
2	FARIA S S, COSTANTINI S, DE LIMA V C C, et al. NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer[J]. J Biomed Sci, 2021, 28(1): 26.
3	LOVELESS R, BLOOMQUIST R, TENG Y. Pyroptosis at the forefront of anticancer immunity[J]. J Exp Clin Cancer Res, 2021, 40(1): 264.
4	WANG Y P, GAO W Q, SHI X Y, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin[J]. Nature, 2017, 547(7661): 99-103.
5	GABASHVILI A N, VODOPYANOV S S, CHMELYUK N S, et al. Encapsulin based self-assembling iron-containing protein nanoparticles for stem cells MRI visualization[J]. Int J Mol Sci, 2021, 22(22): 12275.
6	XIAO Y, ZHANG T, MA X B, et al. Microenvironment-responsive prodrug-induced pyroptosis boosts cancer immunotherapy[J]. Adv Sci (Weinh), 2021, 8(24): e2101840.
7	LI M L, KIM J, RHA H, et al. Photon-controlled pyroptosis activation (PhotoPyro): an emerging trigger for antitumor immune response[J]. J Am Chem Soc, 2023, 145(11): 6007-6023.
8	ZHU Y, DENG J L, LU H W, et al. Reverse magnetic resonance tuning nanoplatform with heightened sensitivity for non-invasively multiscale visualizing ferroptosis-based tumor sensitization therapy[J]. Biomaterials, 2025, 315: 122935.
9	NTZIACHRISTOS V, PLEITEZ M A, AIME S, et al. Emerging technologies to image tissue metabolism[J]. Cell Metab, 2019, 29(3): 518-538.
10	YUAN Y, WANG C X, KUDDANNAYA S, et al. In vivo tracking of unlabelled mesenchymal stromal cells by mannose-weighted chemical exchange saturation transfer MRI[J]. Nat Biomed Eng, 2022, 6(5): 658-666.
11	JONES K M, POLLARD A C, PAGEL M D. Clinical applications of chemical exchange saturation transfer (CEST) MRI[J]. J Magn Reson Imaging, 2018, 47(1): 11-27.
12	JIN T, NICHOLLS F J, CRUM W R, et al. Diamagnetic chemical exchange saturation transfer (diaCEST) affords magnetic resonance imaging of extracellular matrix hydrogel implantation in a rat model of stroke[J]. Biomaterials, 2017, 113: 176-190.
13	LI Y G, CHEN H W, XU J D, et al. CEST theranostics: label-free MR imaging of anticancer drugs[J]. Oncotarget, 2016, 7(6): 6369-6378.
14	FILIPPOV S K, STAROVOYTOVA L, KONÁK C, et al. pH sensitive polymer nanoparticles: effect of hydrophobicity on self-assembly[J]. Langmuir, 2010, 26(18): 14450-14457.
15	ZHAO P F, WANG M, CHEN M, et al. Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy[J]. Biomaterials, 2020, 254: 120142.
16	SHEN X J, WANG H B, WENG C H, et al. Caspase 3/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity[J]. Cell Death Dis, 2021, 12(2): 186.
17	WU J L, LIN S, WAN B, et al. Pyroptosis in liver disease: new insights into disease mechanisms[J]. Aging Dis, 2019, 10(5): 1094-1108.
18	YUAN Y, ZHANG J, QI X L, et al. Furin-mediated intracellular self-assembly of olsalazine nanoparticles for enhanced magnetic resonance imaging and tumour therapy[J]. Nat Mater, 2019, 18(12): 1376-1383.
19	LI L, TIAN H L, ZHANG Z, et al. Carrier-free nanoplatform via evoking pyroptosis and immune response against breast cancer[J]. ACS Appl Mater Interfaces, 2023, 15(1): 452-468.

[1]	WANG Jingyi, DENG Jiali, ZHU Yi, DING Xinyi, GUO Jiajing, WANG Zhongling. Experimental study on novel pH-responsive manganese-based nanoprobes for ferroptosis and magnetic resonance imaging in breast cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(9): 1183-1193.
[2]	WU Shiyi, CHEN Si, LIU Bohan, LIU Yuting, LIU Yiwen, HE Yiqing, DU Yan, ZHANG Guoliang, GUO Qian, GAO Feng, YANG Cuixia. Role of "HA coat" in modulating stemness and endocrine resistance in ER⁺ breast cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(10): 1298-1307.
[3]	WU Qizhen, LIU Qiming, CHAI Yezi, TAO Zhengyu, WANG Yinan, GUO Xinning, JIANG Meng, PU Jun. Evaluation of machine learning prediction of altered inflammatory metabolic state after neoadjuvant therapy for breast cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(9): 1169-1181.
[4]	HAN Yishan, XU Ziqi, TAO Mengyu, FAN Guangjian, YU Bo. PRMT6 promotes the proliferation and migration of breast cancer cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(8): 999-1010.
[5]	WANG Wei, WANG Hongli, ALIBIYATI·i Ain, YILIYAER· Rousu, AYI NUER, YANG Liang. Function of vasohibin-2 and the mechanism of alternative splicing in triple-negative breast cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(12): 1526-1535.
[6]	TAN Chen, XU Zhangrun, XUE Yang, CHEN Jiayu, YAO Lijun. Research progress in drug repurposing in the treatment of breast cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(11): 1454-1459.
[7]	DU Shaoqian, TAO Mengyu, CAO Yuan, WANG Hongxia, HU Xiaoqu, FAN Guangjian, ZANG Lijuan. CXCL9 expression in breast cancer and its correlation with the characteristics of tumor immunoinfiltration [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(7): 860-872.
[8]	CAO Yuan, WANG Hongxia, ZHU Ying, LI Junjian. Expression of tetraspanin 1 in breast cancer and its mechanism in promoting the progression of breast cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(3): 293-300.
[9]	ZHENG Xiaoyan, WANG Xingyun, ZHANG Yongjun. Improvement of alveolarization arrest in newborn rats with bronchopulmonary dysplasia via inhibiting alveolar epithelial cell pyroptosis [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(2): 171-179.
[10]	YANG Xiaoxuan, ZHU Shan, QIAN Cheng, CHU Xiaoying. Effect of intraoperative use of low-dose dexmedetomidine on the prognosis of patients undergoing breast cancer surgery [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(2): 194-200.
[11]	CHEN Zixuan, LI Dong, LIU Min. Review of the role of pyroptosis in benign prostatic hyperplasia in old males [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(12): 1569-1576.
[12]	WANG Lanxi, MA Guanrong, JIANG Yongzhu, CHANG Xiulin, FANG Liaoqiong, BAI Jin. Effects of Escherichia coli outer membrane vesicles on proliferation of breast cancer cells and tumor growth of tumor-bearing mice [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(10): 1245-1254.
[13]	XIA Kunjian, DENG Linlin, WANG Lin. Construction and evaluation of a prediction model for liver injury induced by chemotherapy for breast cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(4): 502-509.
[14]	ZHANG Yutang, JIN Yijie, ZHANG Fengchun, XU Yingchun. Exploration on rationalization of diagnosis and treatment of breast cancer patients combined with COVID-19 [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(12): 1745-1750.
[15]	SU Juncheng, WANG Yuzheng, TANG Lei, XU Yingchun, ZHANG Fengchun. Clinical and pathological characteristics as well as prognostic analysis of breast cancer patients with brain metastases [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(11): 1562-1568.